Alimta and thrombocytopenia Patient Reports February 12, 2012
Alimta Side Effects Report #4844599-X
Alimta side effect was reported by a Physician from UNITED STATES on Nov 10, 2005. Female patient, 82 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood calcium decreased, hypomagnesaemia, thrombocytopenia, white blood cell count decreased. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5016326-7
Alimta side effect was reported by a Physician from FRANCE on May 16, 2006. Male patient, 70 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, diabetes mellitus inadequate control, jaundice cholestatic, neutropenia, thrombocytopenia, treatment noncompliance. Alimta dosage: 500 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYANOCOBALAMIN, CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5931663-7
Alimta side effect was reported by a Physician from FRANCE on Oct 17, 2008. Male patient, 83 years of age, weighting 194.0 lb, was diagnosed with pleural mesothelioma, vitamin supplementation, prophylaxis, hypertension, pain
, reflux gastritis and was treated with Alimta. After drug was administered, patient experienced the following side effects: cardiogenic shock, hypercreatininaemia, neutropenia, pancytopenia, septic shock, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, SPECIAFOLDINE, VITAMIN B, CORTICOSTEROIDS, ZESTORETIC, TOPALGIC, OMEPRAZOLE, GAVISCON. Patient was hospitalized. Patient died on 08/26/2008.Alimta Side Effects Report #5155037-4
Alimta side effect was reported by a Physician from GERMANY on Nov 14, 2006. Male patient was diagnosed with pleural mesothelioma and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXMETHSONE. Patient died.
Alimta Side Effects Report #5598535-1
Alimta side effect was reported by a Physician from GERMANY on Jan 14, 2008. Male patient was diagnosed with pleural mesothelioma, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemorrhage, pancytopenia, rash
, renal failure, thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with DEXAMETHASONE, FOLIC ACID, VITAMINS NOS. Patient died on 01/12/2008.Alimta Side Effects Report #5281459-7
Alimta side effect was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Male patient, 58 years of age, weighting 176.4 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: ascites, blood creatinine increased, febrile neutropenia, thrombocytopenia, white blood cell count decreased. Alimta dosage: 1,000 MG ONCE IV. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4666567-3
Alimta side effect was reported by a Health Professional from on Apr 28, 2005. Female patient, 84 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, disease progression, thrombocythaemia, thrombocytopenia. Alimta dosage: 1000 MG OTHER. During the same period patient was treated with GEMZAR, FOLIC ACID, VITAMIN B, DECADRON, ARANESP, LEVOXYL. Patient recovered.
Alimta Side Effects Report #5339541-1
Alimta side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. Patient recovered.
Alimta Side Effects Report #4875955-1
Alimta side effect was reported by a Physician from UNITED STATES on Sept 16, 2005. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Alimta dosage: unknown. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5286554-4
Alimta side effect was reported by a Physician from UNITED STATES on Mar 29, 2007. Male patient, 70 years of age, weighting 211.0 lb, was diagnosed with non-small cell lung cancer metastatic, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: azotaemia, diarrhoea, neutropenia, thrombocytopenia. Alimta dosage: 1000 MG, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5293011-8
Alimta side effect was reported by a Physician from UNITED STATES on Apr 05, 2007. Male patient, 70 years of age, weighting 211.0 lb, was diagnosed with non-small cell lung cancer metastatic, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: azotaemia, diarrhoea, neutropenia, thrombocytopenia. Alimta dosage: 1000 MG, UNK. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4662319-9
Alimta side effect was reported by a Pharmacist from on Apr 25, 2005. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, deep vein thrombosis
, haemoptysis, neutrophil count increased, thrombocytopenia. Alimta dosage: 700 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #5973200-7
Alimta side effect was reported by a Physician from UNITED STATES on Nov 20, 2008. Female patient, 47 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: cerebral infarction, embolism, gastrointestinal haemorrhage, thrombocytopenia. Alimta dosage: 750 MG, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient died on 01/01/2008.
Alimta Side Effects Report #5645020-4
Alimta side effect was reported by a Physician from UNITED STATES on Feb 20, 2008. Male patient, weighting 147.7 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, anal fistula, blood creatinine increased, dyspnoea exertional, malignant neoplasm progression, thrombocytopenia. Alimta dosage: 724 MG, OTHER; 1 DOSE. During the same period patient was treated with NIFEDIPINE, DEXAMETHASONE, FERROUS SULPHATE, NOVOLOG, VICODIN, ZETIA, DIPYRIDAMOLE, ACTOS. Patient was hospitalized. Patient died on 01/18/2007.
Alimta Side Effects Report #4797322-1
Alimta side effect was reported by a Health Professional from UNITED STATES on June 29, 2005. Male patient, 88 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, thrombocytopenia. Alimta dosage: 500 MG/M2. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4642427-9
Alimta side effect was reported by a Physician from on Apr 06, 2005. Female patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: dermatitis, thrombocytopenia. Alimta dosage: 500 MG/M2 OTHER. During the same period patient was treated with STEROIDS, VITAMIN B, FOLIC ACID. Patient recovered.
Alimta Side Effects Report #5349499-7
Alimta side effect was reported by a Physician from UNITED STATES on June 04, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: leukoencephalopathy, neutropenia, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.
Alimta Side Effects Report #5391065-1
Alimta side effect was reported by a Physician from UNITED STATES on July 16, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: leukoencephalopathy, neutropenia, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with AVASTIN, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5389474-X
Alimta side effect was reported by a Physician from FRANCE on July 11, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: leukopenia, purpura, pyrexia, rash pruritic, stomatitis, thrombocytopenia. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with LEVOFLOXACIN, NAVELBINE, CARBOPLATIN, SPECIAFOLDINE, MONOTILDIEM. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5309915-3
Alimta side effect was reported by a Physician from FRANCE on Apr 19, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, thrombocytopenia. Alimta dosage: 500 MG/M2, OTHER. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4684793-4
Alimta side effect was reported by a Health Professional from on Mar 08, 2005. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, leukopenia, nausea
, rash macular, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with DEXAMETHASONE, VITAMIN B, FOLIC ACID, LORAZEPAM, MAXZIDE, REGLAN, EFFEXOR. Patient recovered.Alimta Side Effects Report #4935265-0
Alimta side effect was reported by a Physician from UNITED STATES on Feb 17, 2006. Female patient, 66 years of age, weighting 150.1 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: 890 MG. During the same period patient was treated with VITAMIN B12, FOLIC ACID, CARBOPLATIN. Patient recovered.
Alimta Side Effects Report #4949442-6
Alimta side effect was reported by a Physician from UNITED STATES on Mar 01, 2006. Female patient, 66 years of age, weighting 150.1 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: 890 MG. During the same period patient was treated with VITAMIN B12, FOLIC ACID, CARBOPLATIN. Patient recovered.
Alimta Side Effects Report #4955063-1
Alimta side effect was reported by a Physician from UNITED STATES on Mar 09, 2006. Female patient, 66 years of age, weighting 150.1 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: 890 MG. During the same period patient was treated with VITAMIN B12, FOLIC ACID, CARBOPLATIN. Patient recovered.
Alimta Side Effects Report #4684771-5
Alimta side effect was reported by a Physician from on Apr 08, 2005. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient recovered.
Alimta Side Effects Report #5940216-6
Alimta side effect was reported by a Physician from AUSTRIA on Oct 23, 2008. Male patient, 61 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: duodenitis, gastritis erosive, oesophagitis, renal failure acute, thrombocytopenia, upper gastrointestinal haemorrhage. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, VOLTAREN. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #6016102-2
Alimta side effect was reported by a Physician from AUSTRIA on Dec 15, 2008. Male patient, 61 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: duodenitis, gastritis erosive, large intestinal ulcer, oesophageal ulcer, oesophagitis, renal failure acute, thrombocytopenia, upper gastrointestinal haemorrhage. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, VOLTAREN. Patient was hospitalized. Patient died on 01/01/2008.Alimta Side Effects Report #4806755-6
Alimta side effect was reported by a Physician from FRANCE on Sept 29, 2005. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: atrial flutter, neutropenia, overdose, septic shock, thrombocytopenia. Alimta dosage: 500 MG/M2/ 1 OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4987801-6
Alimta side effect was reported by a Physician from FRANCE on Apr 10, 2006. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: haematoma, thrombocytopenia. Alimta dosage: 500 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, FOLIC ACID, CYANOCOBALAMIN, CORTICOSTEROID NOS, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5202320-X
Alimta side effect was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: epistaxis, purpura, thrombocytopenia. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5402373-X
Alimta side effect was reported by a Physician from FRANCE on July 25, 2007. Female patient, 58 years of age, weighting 207.2 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation, diabetes mellitus, hypertension, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, beta haemolytic streptococcal infection, candida sepsis, febrile neutropenia, malignant neoplasm progression, renal failure, thrombocytopenia. Alimta dosage: 1000 MG, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, METFORMINE, COKENZEN, MICARDIS, DEXAMETHASONE, DURAGESIC. Patient was hospitalized. Patient died on 04/03/2007.
Alimta Side Effects Report #5228046-4
Alimta side effect was reported by a Health Professional from UNITED STATES on Oct 26, 2006. Male patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: 500 MG/M2, INTRAVENOUS. During the same period patient was treated with COUMADIN, VITAMIN B12, FOLIC ACID, DEXAMETHASONE. Patient recovered.
Alimta Side Effects Report #5828743-3
Alimta side effect was reported by a Physician from SWITZERLAND on July 22, 2008. Male patient, 49 years of age, weighting 213.8 lb, was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastric haemorrhage, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with MS CONTIN, DAFALGAN, NOVALGIN, VITAMIN B, FOLIC ACID, FORTECORTIN. Patient was hospitalized. Patient died on 04/21/2008.Alimta Side Effects Report #5051748-X
Alimta side effect was reported by a Health Professional from UNITED STATES on June 16, 2006. Female patient, 47 years of age, weighting 133.4 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood creatinine increased, erythema, neutrophil count decreased, pruritus, thrombocytopenia, white blood cell count decreased. Alimta dosage: 795 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, CYANOCOBALAMIN, FOLIC ACID, COUMADIN, ZOCOR, NEURONTIN, AVANDIA, ACIPHEX. Patient recovered.
Alimta Side Effects Report #4705394-5
Alimta side effect was reported by a Physician from on June 30, 2005. Female patient, 47 years of age, weighting 133.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: mucosal inflammation, neutropenia, renal failure, thrombocytopenia. Alimta dosage: 800 MG Q 3 WEEKS. During the same period patient was treated with THALIDOMIDE, VIT B, FOLIC ACID. Patient was hospitalized. Patient died on 06/19/2005.
Alimta Side Effects Report #5256677-4
Alimta side effect was reported by a Physician from FRANCE on Feb 26, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, thrombocytopenia. Alimta dosage: 500 MG/M2, OTHER. Patient recovered.
Alimta Side Effects Report #5604532-X
Alimta side effect was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, weighting 218.3 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: dehydration, enanthema, rash maculo-papular, thrombocytopenia. Alimta dosage: unknown. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5780469-0
Alimta side effect was reported by a Physician from UNITED STATES on June 12, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5807328-9
Alimta side effect was reported by a Physician from UNITED STATES on July 02, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. Patient was hospitalized. Patient died.
Alimta Side Effects Report #5816032-2
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID, CORTICOSTEROID NOS. Patient was hospitalized. Patient died.
Alimta Side Effects Report #5887504-X
Alimta side effect was reported by a Health Professional from UNITED STATES on Sept 17, 2008. Male patient, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, disease progression, neutropenia, thrombocytopenia. Alimta dosage: 900 MG EVERY 3 WEEKS IV. Patient was hospitalized. Patient died on 09/08/2008.
Alimta Side Effects Report #6089374-6
Alimta side effect was reported by a Physician from GERMANY on Feb 11, 2009. Male patient, weighting 211.6 lb, was diagnosed with non-small cell lung cancer, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: diarrhoea haemorrhagic, jaundice
, neutropenia, thrombocytopenia, vein disorder. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, FOLIC ACID, VITAMIN B, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4982131-0
Alimta side effect was reported by a Physician from UNITED STATES on Mar 28, 2006. Female patient, 59 years of age, was diagnosed with nasopharyngeal cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia, vaginal haemorrhage. Alimta dosage: 500 MG/M2. During the same period patient was treated with CYANOCOBALAMIN, FOLIC ACID, DECADRON. Patient recovered.
Alimta Side Effects Report #5636492-X
Alimta side effect was reported by a Physician from BELGIUM on Feb 14, 2008. Male patient, 51 years of age, was diagnosed with metastases to bone and was treated with Alimta. After drug was administered, patient experienced the following side effects: neutropenia, thrombocytopenia, vasculitis gastrointestinal. Alimta dosage: unknown. During the same period patient was treated with CORTICOSTEROID NOS, VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4957340-7
Alimta side effect was reported by a Physician from UNITED STATES on Mar 10, 2006. Male patient, 65 years of age, was diagnosed with mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, neutropenia, pleural effusion, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died.
Alimta Side Effects Report #5309909-8
Alimta side effect was reported by a Physician from UNITED STATES on Apr 19, 2007. Male patient, 58 years of age, weighting 176.4 lb, was diagnosed with mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood creatinine increased, febrile neutropenia, thrombocytopenia. Alimta dosage: 1000 MG, UNK. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4799840-9
Alimta side effect was reported by a Physician from FRANCE on Sept 27, 2005. Female patient, 78 years of age, weighting 156.5 lb, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: leukopenia, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with LAMALINE, ALLOPURINOL, INNOHEP, CIPROFLOXACIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5067911-8
Alimta side effect was reported by a Physician from ITALY on July 13, 2006. Female patient, 71 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: confusional state, neutropenia, platelet count decreased, renal failure, somnolence, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5117621-3
Alimta side effect was reported by a Physician from ITALY on Sept 05, 2006. Female patient, 71 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood sodium decreased, confusional state, neutropenia, renal failure acute, somnolence, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5158648-5
Alimta side effect was reported by a Physician from ITALY on July 13, 2006. Female patient, 71 years of age, was diagnosed with lung neoplasm malignant, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: neutropenia, platelet count decreased, renal failure acute, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4853702-7
Alimta side effect was reported by a Physician from FRANCE on Dec 01, 2005. Male patient, 63 years of age, weighting 132.3 lb, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, neutropenia, purpura, rash pustular, renal failure acute, septic shock, skin exfoliation, thrombocytopenia. Alimta dosage: 885 MG, OTHER, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/25/2005.
Alimta Side Effects Report #5164699-7
Alimta side effect was reported by a Physician from SINGAPORE on May 25, 2006. Male patient, 47 years of age, was diagnosed with lung neoplasm malignant, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID. Patient was hospitalized. Patient died.
Alimta Side Effects Report #5449105-7
Alimta side effect was reported by a Physician from FRANCE on Sept 04, 2007. Male patient, 37 years of age, was diagnosed with lung neoplasm malignant, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, blood creatine phosphokinase increased, cytolytic hepatitis, grand mal convulsion, hepatic failure, hyperkalaemia, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with AREDIA, VITAMIN B. Patient was hospitalized. Patient died on 06/03/2007.
Alimta Side Effects Report #5764714-3
Alimta side effect was reported by a Physician from FRANCE on May 26, 2008. Male patient was diagnosed with lung cancer metastatic, vitamin supplementation, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: eczema
, febrile bone marrow aplasia, mucosal inflammation, neutropenia, skin toxicity, staphylococcal bacteraemia, thrombocytopenia. Alimta dosage: 975 MG EVERY FOUR WEEKS. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, ZOMETA, ZOPHREN, DURAGESIC. Patient died on 02/24/2008.Alimta Side Effects Report #5328840-5
Alimta side effect was reported by a Physician from FRANCE on May 14, 2007. Female patient, 67 years of age, weighting 149.9 lb, was diagnosed with lung adenocarcinoma metastatic, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hemiplegia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: 800 MG, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized and became disabled. Patient died.
Alimta Side Effects Report #6081629-4
Alimta side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Female patient, 58 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, clostridium difficile colitis, granulocytopenia, neutropenia, respiratory tract infection, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5756995-7
Alimta side effect was reported by a Physician from GREECE on May 21, 2008. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma, non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN, SINTROM, DILTIAZEM, ANGORON, ZOCOR, LOSEC I. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5833344-7
Alimta side effect was reported by a Physician from GREECE on July 23, 2008. Male patient, 77 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma, non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B, CARBOPLATIN, SINTROM, DILTIAZEM, ANGORON, ZOCOR, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5025528-5
Alimta side effect was reported by a Consumer or non-health professional from FRANCE on May 30, 2006. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Alimta. After drug was administered, patient experienced the following side effects: dermatitis bullous, haematotoxicity, neutropenia, skin exfoliation, skin toxicity, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with CORTANCYL. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4821858-8
Alimta side effect was reported by a Physician from PERU on Oct 13, 2005. Female patient, 52 years of age, weighting 200.6 lb, was diagnosed with breast cancer
and was treated with Alimta. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, hepatotoxicity, leukopenia, skin hyperpigmentation, thermal burn, thrombocytopenia. Alimta dosage: 925 MG. During the same period patient was treated with DOXORUBICIN, ENALAPRIL, NIFEDIPINE, HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4950025-2
Alimta side effect was reported by a Physician from PERU on Feb 23, 2006. Female patient, 52 years of age, weighting 200.6 lb, was diagnosed with breast cancer
and was treated with Alimta. After drug was administered, patient experienced the following side effects: epistaxis, hepatotoxicity, leukopenia, skin hyperpigmentation, thermal burn, thrombocytopenia. Alimta dosage: 925 MG, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE, NIFEDIPINE, HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4620587-3
Alimta side effect was reported by a Pharmacist from on Mar 04, 2005. Female patient, 67 years of age, was diagnosed with blood fibrinogen decreased and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood fibrinogen decreased, deep vein thrombosis
, haemoptysis, neutrophil count increased, thrombocytopenia. Alimta dosage: 700 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4797342-7
Alimta side effect was reported by a Health Professional from UNITED STATES on May 23, 2005. Male patient, 54 years of age, was diagnosed with bladder cancer
and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, anorexia, fatigue, haemolytic anaemia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, VITAMIN B, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4992347-5
Alimta side effect was reported by a Health Professional from UNITED STATES on May 25, 2005. Male patient, 54 years of age, was diagnosed with bladder cancer
and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, anorexia, fatigue, haemolytic anaemia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, VITAMIN B12, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #6089373-4
Alimta side effect was reported by a Physician from HUNGARY on Feb 18, 2009. Male patient, weighting 264.6 lb, was diagnosed with adenocarcinoma and was treated with Alimta. After drug was administered, patient experienced the following side effects: neutropenia, rash
, thrombocytopenia. Alimta dosage: 1200 MG, OTHER. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B, MEDROL, ZOMETA. Patient was hospitalized. Patient died on 01/21/2009.Alimta Side Effects Report #5370263-7
Alimta side effect was reported by a Health Professional from UNITED STATES on June 25, 2007. Male patient, 75 years of age, weighting 201.0 lb, was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, duodenal ulcer haemorrhage, neutrophil count abnormal, thrombocytopenia. Alimta dosage: 500MG/M2. During the same period patient was treated with ERBITUX. Patient died on 06/22/2007.
Alimta Side Effects Report #5219062-7
Alimta side effect was reported by a Physician from FRANCE on Jan 19, 2007. Female patient, 69 years of age, was treated with Alimta. After drug was administered, patient experienced the following side effects: cerebrovascular accident, thrombocytopenia. Alimta dosage: unknown. Patient recovered.
Alimta Side Effects Report #5197093-3
Alimta side effect was reported by a Physician from FRANCE on Dec 20, 2006. Male patient, 67 years of age, weighting 218.3 lb, was treated with Alimta. After drug was administered, patient experienced the following side effects: renal failure acute, thrombocytopenia. Alimta dosage: unknown. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5303235-9
Alimta side effect was reported by a Physician from FRANCE on Apr 13, 2007. Male patient, 67 years of age, weighting 218.3 lb, was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, melanodermia, mucosal inflammation, neutropenia, prothrombin time ratio decreased, renal failure acute, thrombocytopenia. Alimta dosage: unknown. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #6128218-0
Alimta side effect was reported by a Physician from ISRAEL on Mar 10, 2009. Male patient, 65 years of age, was treated with Alimta. After drug was administered, patient experienced the following side effects: ascites, blood bilirubin increased, neutropenia, overdose, respiratory disorder, thrombocytopenia. Alimta dosage: 700 MG, ONCE EVERY 3 WEEKS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Alimta and thrombocytopenia 